PROFUSA, INC. Operating Lease Cost
PROFUSA, INC. (PFSA) reported Operating Lease Cost of $33.00 thousand for the 12-month period ending 2025-12-31, per its S-1/A filed 2026-05-01.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-05-01
- PROFUSA, INC. operating lease, cost for the quarter ending 2025-12-31 was -$42.00K.
- PROFUSA, INC. operating lease, cost for the quarter ending 2025-09-30 was $75.00K, a 50.00% decline year-over-year.
- PROFUSA, INC. operating lease, cost for the quarter ending 2024-09-30 was $150.00K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$42.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $33.00K derived: sum of 2 quarters · filed 2026-05-01 | $33.00K S-1/A · filed 2026-05-01 | |
| 2025-09-30 | $75.00K 10-Q · filed 2025-11-19 | $75.00K 10-Q · filed 2025-11-19 | ||
| 2024-09-30 | $150.00K 10-Q · filed 2025-11-19 | $150.00K 10-Q · filed 2025-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |